CHICAGO and NEW YORK: RF Binder Partners has chosen Della Burns to head its new healthcare division. She will be responsible for managing new assignments for Eli Lilly's Lilly Reintegration Program. Burns previously worked for Robert Becker Euro RSCG.RF Binder has also just been appointed to handle brand support for Levoxyl, a King Pharmaceutical Corporation treatment, and the Synaptic Pharmaceutical Corporation.
The Ruder Finn-owned company has also launched an international development marketing division. It will offer marketing and communications services for foreign direct investment, location positioning, foreign trade promotion, market research, tourism promotion, and issues and crisis management.
The new division will be run out of New York and London.